Minireviews
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Oct 18, 2021; 11(10): 410-420
Published online Oct 18, 2021. doi: 10.5500/wjt.v11.i10.410
Hemodynamic management in brain dead donors
Chiara Lazzeri, Manuela Bonizzoli, Cristiana Guetti, Giorgio Enzo Fulceri, Adriano Peris
Chiara Lazzeri, Manuela Bonizzoli, Cristiana Guetti, Giorgio Enzo Fulceri, Adriano Peris, Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero Universitaria Careggi, Florence 50134, Italy
Author contributions: Lazzeri C, Peris A, Bonizzoli M performed the majority of the writing, prepared the tables; Guetti C performed data accusation and writing; Fulceri GE provided the input in writing the paper.
Conflict-of-interest statement: No conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chiara Lazzeri, MD, Senior Researcher, Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero Universitaria Careggi, Viale Morgagni 85, Florenze 50134, Italy. lazzeri.ch@gmail.com
Received: March 20, 2021
Peer-review started: March 20, 2021
First decision: July 18, 2021
Revised: July 22, 2021
Accepted: September 10, 2021
Article in press: September 10, 2021
Published online: October 18, 2021
Processing time: 208 Days and 0.1 Hours
Core Tip

Core Tip: Donor management continues critical care but with different and specific therapeutic goals since the number of donor goals met is related to the number of organs retrieved and transplanted. Careful monitoring of selected parameters (possibly including serial echocardiography) is the clinical tool able to guarantee the achievement and maintaining of therapeutic goals. In the single patient, therapeutic regimen (imprimis vasoactive drugs) should be chosen also according to the potential organs retrievable (i.e. heart vs liver and kidneys).